Elysium Therapeutics
PrivateLast Round
SAFE
Jan 28, 2026
Total Funding Raised
$11.49M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Elysium Therapeutics is a biopharmaceutical company developing treatments to rescue and reverse overdoses caused by oral synthetic opioids, such as fentanyl.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elysium Therapeutics Comparables
Compare Elysium Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Consegna Pharma Inc. | 87% | |
| CounterX Therapeutics | 78% | |
| Cessation Therapeutics | 78% | |
Elysium Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| SAFE | Jan 28, 2026 | ||||
| Seed | Dec 20, 2017 | ||||
| Grant | Dec 7, 2017 |
Key People
Founding team and executive leadership
Elysium Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ohio Third Frontier | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 144% MoM.
- Jun 18, 2026
Monthly visitors increased 225% MoM.
Elysium Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |